Sonic Healthcare Limited (CH:SAB)
:SAB
SAB Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Cash GenerationMaterial free cash flow growth and a high operating-cash-to-income ratio indicate durable cash conversion. This supports sustainable dividends, funds organic capex and automation, services acquisition-related debt, and underpins capital returns or buybacks without eroding core operations.
Diversified Organic GrowthConsistent ~5% organic growth across multiple geographies and services reflects resilient structural demand for diagnostics. Diversification across Australia, Germany, UK and Radiology lowers reliance on any single market and supports steady revenue over the medium term.
Margin Expansion & Operational LeverageSequential margin expansion and targeted productivity (hub labs, automation, procurement savings) show sustainable cost-efficiency gains. Realized synergies from integrations and platform investments should continue to support margins and cash flow over the coming quarters.
Bears Say
U.S. Margin PressureThe U.S. business is a significant revenue contributor and restructuring indicates structural margin weakness. Realizing cost-out and network rationalization can take multiple quarters, keeping near-term U.S. profitability and cash conversion under pressure.
Higher Leverage From Acquisitions & PropertyElevated debt and recent acquisition/property spending increase interest exposure and reduce balance sheet flexibility. With guidance noting higher interest expense, leverage limits optionality for aggressive M&A or buybacks and raises sensitivity to rate moves over the medium term.
Working-capital / Collections DisruptionBilling disruption inflated receivables and deferred cash collection benefits into FY2027, increasing net debt and reducing liquidity. Slower cash conversion raises financing needs and creates earnings timing uncertainty that can persist while billing workflows normalize.
Sonic Healthcare Limited News
SAB FAQ
What was Sonic Healthcare Limited’s price range in the past 12 months?
Currently, no data Available
What is Sonic Healthcare Limited’s market cap?
Sonic Healthcare Limited’s market cap is CHF5.61B.
When is Sonic Healthcare Limited’s upcoming earnings report date?
Sonic Healthcare Limited’s upcoming earnings report date is Aug 20, 2026 which is in 60 days.
How were Sonic Healthcare Limited’s earnings last quarter?
Sonic Healthcare Limited released its earnings results on Feb 18, 2026. The company reported CHF0.282 earnings per share for the quarter, missing the consensus estimate of CHF0.297 by -CHF0.015.
Is Sonic Healthcare Limited overvalued?
According to Wall Street analysts Sonic Healthcare Limited’s price is currently Undervalued.
Does Sonic Healthcare Limited pay dividends?
Sonic Healthcare Limited does not currently pay dividends.
What is Sonic Healthcare Limited’s EPS estimate?
Sonic Healthcare Limited’s EPS estimate is 0.38.
How many shares outstanding does Sonic Healthcare Limited have?
Sonic Healthcare Limited has 494,237,950 shares outstanding.
What happened to Sonic Healthcare Limited’s price movement after its last earnings report?
Sonic Healthcare Limited reported an EPS of CHF0.282 in its last earnings report, missing expectations of CHF0.297. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Sonic Healthcare Limited?
Currently, no hedge funds are holding shares in CH:SAB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Sonic Healthcare Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
CHF12.71 (― Downside)
CHF12.71 (― Downside)
Blogger Sentiment
Bullish
CH:SAB Sentiment 100%
Sector Average ―
Sector Average ―
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-16.74%
12-Months-Change
Fundamentals
Return on Equity
6.39%
Trailing 12-Months
Asset Growth
10.74%
Trailing 12-Months
Company Description
Sonic Healthcare Limited
Sonic Healthcare Limited delivers medical diagnostic services to a diverse clientele, including medical professionals, hospitals, public health organizations, and individual patients. The company's services encompass a broad spectrum of laboratory medicine and pathology testing, covering biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal diagnostics, toxicology, and other related functions. Furthermore, Sonic provides extensive radiology services, such as magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. Its offerings also extend to primary care medical services, featuring general practice clinics, occupational health, specialized skin cancer clinics, after-hours GP services, IT solutions for general practices, and various community-based healthcare programs. Operating internationally, the company has a significant presence in Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, and Belgium. Founded in 1934, Sonic Healthcare Limited is headquartered in Sydney, Australia.
SAB Stock 12 Month Forecast
Average Price Target
CHF12.71
Healius Limited
―
Genetic Signatures Ltd.
―
Integral Diagnostics Ltd.
―
Australian Clinical Labs Ltd
―
Monash IVF Group Ltd
―
Options Prices
Currently, No data available
---